JonathanDanielNewmanMD
Cardiology • New York, NYAdult Congenital Heart Disease, Preventive Cardiology
Associate Professor of Medicine (Cardiology), Director Clinical Research, Center for the Prevention of Cardiovascular Disease, New York University Grossman School of Medicine
Dr. Newman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
177 Fort Washington Ave.
6th Floor, Ctr 12
New York, NY 10032Phone+1 212-305-2913
Education & Training
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2009 - 2013- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2005 - 2008
Northwestern University The Feinberg School of MedicineClass of 2005
Certifications & Licensure
NY State Medical License 2007 - 2026- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Vegan vs AHA Diet on Inflammation and Glucometabolic Profile in Patients With CAD Start of enrollment: 2014 Mar 11
Publications & Presentations
PubMed
- 4 citationsAtherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.Nick S Nurmohamed, James K Min, Rebecca Anthopolos, Harmony R Reynolds, James P Earls
European Heart Journal. 2024-09-29 - Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials.Carine E Hamo, Richard Liu, Wenbo Wu, Rebecca Anthopolos, Sripal Bangalore
The American Journal of Cardiology. 2024-08-15 - 3 citationsBaseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).Ana Navas-Acien, Regina M Santella, Bonnie R Joubert, Zhen Huang, Yuliya Lokhnygina
American Heart Journal. 2024-07-01
Journal Articles
- Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of DiabetesVivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism
- The Changing Landscape of Diabetes Therapy for Cardiovascular Risk ReductionArthur Z Schwartzbard, Jonathan D Newman, Howard S Weintraub, Jeffrey S Berger, Anish K Vani, ScienceDirect
Press Mentions
NYU Langone Heart’s Leading Cardiologists Present Latest Research at the American Heart Association’s Scientific Sessions 2024November 17th, 2024- News Coverage of NYU Langone Health for Tuesday, May 9, 2023May 10th, 2023
- Diabetes Drugs May Help Reduce Risk of Cardiovascular Events in Older AdultsMay 8th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
